<p>Bruker Corporation has provided preliminary financial guidance for the fourth quarter and full year 2026. The company expects fourth quarter 2025 revenue to be between $965 million and $970 million, with its Bruker Scientific Instruments segments reporting a book-to-bill ratio above 1.0. For the full year ending December 31, 2026, Bruker anticipates organic revenue growth will be flat to up in the low-single digits compared to 2025. Additionally, non-GAAP organic operating margins are expected to expand by 250 to 300 basis points, while non-GAAP earnings per share are projected to increase by double digits year-over-year. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-010106), on January 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

Bruker Projects Flat to Low-Single Digit Organic Revenue Growth for 2026